SmPC - Gabapentin Accord 400mg Hard Capsules: Change history
View Summary of Product Characteristics (SmPC - Gabapentin Accord 400mg Hard Capsules)
Last updated on this site: 12 Aug 2024
HPRA request to update pharmacotherapeutic group error in SmPC section 5.1.
Last updated on this site: 12 Aug 2024
HPRA request to update pharmacotherapeutic group error in SmPC section 5.1.
-
Changes: (Updated: 12 Aug 2024)
HPRA request to update pharmacotherapeutic group error in SmPC section 5.1.
-
Changes: (Updated: 13 Mar 2023)
Description of update: C.I.3.a - SAFETY, EFFICACY, PHARMACOVIGILANCE CHANGES - HUMAN AND VETERINARY MEDICINAL PRODUCTS - Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of human medicinal products intended to implement the outcome of a procedure concerning PSUR or PASS, or the outcome of the assessment done by the competent authority under Articles 45 or 46 of Regulation 1901/2006 - Implementation of wording agreed by the competent authority: Type IAIN (C.I.3.a) To update the SPC and PIL in-line with wording of PSUSA (PSUSA/00001499/202202 published on EC) procedure. A.6 - ADMINISTRATIVE CHANGES - Change in ATC Code / ATC Vet Code: Type IA (A.6) To update the ATC Code for “Gabapentin” as published by WHO.
SmPC sections updated: 4.4, 4.5, 4.6, 4.8, 5.1, 10.
-
Changes: (Updated: 22 Sep 2022)
Initial upload